Company lists · Data refreshed September 2026

Top 24 Combination cancer therapy companies based in China

RevenueBase identified 122 combination cancer therapy companies headquartered in China as of September 2026 and tracks 2,170 professional contacts across them, including 217 with verified work emails. Shanghai is the largest hub.

This list covers combination cancer therapy companies headquartered in China, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 19, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 19, 2026 86% judged on-target in blind review
122Companies
2,170Contacts tracked
217Verified emails
Explore this list → Free signup · no credit card · 500 free credits

The 24 largest combination cancer therapy companies based in China

Ranked by team size
Top 24 of 122 combination cancer therapy companies based in China, ranked by team size, largest first. Data refreshed Sep 19, 2026. RevenueBase Smart Search rates how each company's information relates to combination cancer therapy companies: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#CompanyRevenueBase Smart SearchHeadquartersEmployeesContacts
1Indirect evidenceShanghai, ChinaHQ checked Sep 19, 20261,001-5,000291 contacts →

Indirect evidence

“Henlius is a rapidly growing biopharmaceutical provider that develops, manufactures, and distributes leading oncology treatments.”

Source: RevenueBase Database · checked Sep 19, 2026
2Partial evidenceShanghai, ChinaHQ checked Sep 19, 2026201-500136 contacts →

Partial evidence

“CStone (HKEX: 2616), established in late 2015, is an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology…”

Source: RevenueBase Database · checked Sep 19, 2026
3Indirect evidenceBeijing, ChinaHQ checked Sep 19, 20261,001-5,00087 contacts →

Indirect evidence

“InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the…”

Source: RevenueBase Database · checked Sep 19, 2026
4Indirect evidenceShanghai, ChinaHQ checked Sep 19, 2026501-1,00079 contacts →

Indirect evidence

“Dizal Pharmaceutical Co, Ltd (Ticker: 688192 ) is a commercial stage biopharmaceutical company.”

Source: RevenueBase Database · checked Sep 19, 2026
5Indirect evidenceShanghai, ChinaHQ checked Sep 19, 2026501-1,00077 contacts →

Indirect evidence

“CARsgen is a biopharmaceutical company with operations in China and the U.S.”

Source: RevenueBase Database · checked Sep 19, 2026
6Partial evidenceBeijing, ChinaHQ checked Sep 19, 2026501-1,00056 contacts →

Partial evidence

“Genetron Holdings Limited (“Genetron Health” or the “Company”) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and…”

Source: RevenueBase Database · checked Sep 19, 2026
7Partial evidenceSuzhou Industrial Park, ChinaHQ checked Sep 19, 2026201-50051 contacts →

Partial evidence

“Adagene Inc.(Nasdaq: ADAG) is a biotechnology company transforming the discovery and development of novel antibody-based cancer immunotherapies.”

Source: RevenueBase Database · checked Sep 19, 2026
8Indirect evidence上海市, ChinaHQ checked Sep 19, 202651-20036 contacts →

Indirect evidence

“is a management consulting company based out of 452101-04(18), China.”

Source: RevenueBase Database · checked Sep 19, 2026
9Partial evidenceShanghai, ChinaHQ checked Sep 19, 202651-20025 contacts →

Partial evidence

“Founded in 2015, Oricell Therapeutics aims to develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives…”

Source: RevenueBase Database · checked Sep 19, 2026
10Indirect evidence上海市, ChinaHQ checked Sep 19, 202611-5022 contacts →

Indirect evidence

Source: RevenueBase Database · checked Sep 19, 2026
11Indirect evidence成都, ChinaHQ checked Sep 19, 202651-20022 contacts →

Indirect evidence

Source: RevenueBase Database · checked Sep 19, 2026
12Partial evidenceNanjing, ChinaHQ checked Sep 19, 202651-20021 contacts →

Partial evidence

“Biosion is a global R&D biotechnology company committed to developing antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases.”

Source: RevenueBase Database · checked Sep 19, 2026
13Partial evidenceShanghai, ChinaHQ checked Sep 19, 202651-20021 contacts →

Partial evidence

“Dedicated to serving significant unmet medical needs, GenFleet Therapeutics constructs its R&D platform on the basis of disease biology and translational medicine, and researches…”

Source: RevenueBase Database · checked Sep 19, 2026
14Indirect evidenceShanghai, ChinaHQ checked Sep 19, 202651-20016 contacts →

Indirect evidence

“VelaVigo is a leading biotech company specializing in the discovery and development of multispecific antibodies and ADCs.”

Source: RevenueBase Database · checked Sep 19, 2026
15Indirect evidence北京市, ChinaHQ checked Sep 19, 2026201-50014 contacts →

Indirect evidence

“Jacobio Pharma (1167.HK) is committed to developing and providing new and innovative products and solutions to improve people's health.”

Source: RevenueBase Database · checked Sep 19, 2026
16Indirect evidenceShanghai, ChinaHQ checked Sep 19, 2026201-50013 contacts →

Indirect evidence

“02256 HKEx code02256”

Source: RevenueBase Database · checked Sep 19, 2026
17Indirect evidenceShenzhen, ChinaHQ checked Sep 19, 202651-20012 contacts →

Indirect evidence

Source: RevenueBase Database · checked Sep 19, 2026
18Indirect evidenceShanghai, ChinaHQ checked Sep 19, 202611-5011 contacts →

Indirect evidence

“Established in 2018, InxMed strives to be a China-based global new drug development engine dedicated to the development of innovative drugs with high probability of success and…”

Source: RevenueBase Database · checked Sep 19, 2026
19Strong evidenceShanghai, ChinaHQ checked Sep 19, 202651-20010 contacts →

Strong evidence

“Lyvgen is a biopharmaceutical company focused on developing novel therapies for cancer.”

Source: RevenueBase Database · checked Sep 19, 2026
20Indirect evidenceHefei, ChinaHQ checked Sep 19, 202611-508 contacts →

Indirect evidence

Source: RevenueBase Database · checked Sep 19, 2026
21Indirect evidenceShanghai, ChinaHQ checked Sep 19, 20261-106 contacts →

Indirect evidence

Source: RevenueBase Database · checked Sep 19, 2026
22Indirect evidence嘉兴, ChinaHQ checked Sep 19, 202611-504 contacts →

Indirect evidence

“Angel Pharmaceuticals was founded in 2020, focusing on develop, produce and sale of innovative oncology drugs.”

Source: RevenueBase Database · checked Sep 19, 2026
23Indirect evidence苏州, ChinaHQ checked Sep 19, 202651-2004 contacts →

Indirect evidence

Source: RevenueBase Database · checked Sep 19, 2026
24Strong evidenceShanghai, ChinaHQ checked Sep 19, 202611-503 contacts →

Strong evidence

“Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China.”

Source: RevenueBase Database · checked Sep 19, 2026

Showing 24 of 122 combination cancer therapy companies based in China

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 217 reachable decision-makers.

Free signup · no credit card

View the full list →

Combination cancer therapy companies based in China at a glance

As of Sep 19, 2026
10.0%Verified-email coverage
17.8Average contacts per company
51-200Median size (employees)
17.2%Largest-city concentration · Shanghai
Sep 19, 2026Page data refreshed

Companies by employee count

1-10
15
11-50
39
51-200
38
201-500
21
501-1,000
5
1,001-5,000
4

Email recency for this list is measured worldwide rather than for China, so it is reported there. Company counts and contact totals on this page are exact for China, over 122 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among combination cancer therapy companies, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in China whose own description of what they do matches “combination cancer therapy companies”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search
RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names combination cancer therapy companies), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude
Companies whose own description does not clearly place them among combination cancer therapy companies, and records with no verified work email. Companies headquartered outside China are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 217 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 19, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names combination cancer therapy companies, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many combination cancer therapy companies are there based in China?

RevenueBase identified 122 combination cancer therapy companies headquartered in China as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Henlius, headquartered in Xuhui District, tops this list with the largest team on record.

Which city has the most combination cancer therapy companies?

Shanghai leads with 21 headquartered companies, followed by Shang Hai Shi Shang Hai Shi (7) and Suzhou (7).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 217 verified decision-maker contacts tracked across these 122 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 19, 2026.

Ready to reach these companies? Verified emails and direct dials for all 122 combination cancer therapy companies based in China. Start with a free account, no credit card.

Download this list →

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.